Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baba Inusa

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|December 9, 2016
Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemiaJoseph A Jakubowski, Carolyn C Hoppe, Chunmei Zhou, et al.
Haematologica|December 3, 2016
Associations between environmental factors and hospital admissions for sickle cell diseaseFrédéric B Piel, Sanjay Tewari, Valentine Brousse, et al.
Pediatric Blood & Cancer|October 9, 2023
Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open-label FIRST studyMona Hamdy, Amal El-Beshlawy, Mônica P A Veríssimo, et al.
Blood Advances|November 30, 2021
Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority studyJanet L Kwiatkowski, Mona Hamdy, Amal El-Beshlawy, et al.
British Journal of Haematology|May 20, 2011
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell diseaseElliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, et al.
Pediatrics|July 16, 2014
Obstructive sleep apnea and sickle cell anemiaCarol L Rosen, Michael R Debaun, Robert C Strunk, et al.
British Journal of Haematology|March 6, 2019
Index of Pain Experience in Sickle Cell Anaemia (IPESCA): development from daily pain diaries and initial findings from use with children and adults with sickle cell anaemiaJamie M Kawadler, April Slee, Hanne Stotesbury, et al.
British Journal of Haematology|April 25, 2020
Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemicNoémi B A Roy, Paul Telfer, Perla Eleftheriou, et al.
Pediatric Blood & Cancer|November 18, 2014
Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trialNajibah A Galadanci, Shehu U Abdullahi, Musa A Tabari, et al.
Trials|August 26, 2015
Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trialJo Howard, Baba Inusa, Christina Liossi, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|December 9, 2016
Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemiaJoseph A Jakubowski, Carolyn C Hoppe, Chunmei Zhou, et al.
Haematologica|December 3, 2016
Associations between environmental factors and hospital admissions for sickle cell diseaseFrédéric B Piel, Sanjay Tewari, Valentine Brousse, et al.
Pediatric Blood & Cancer|October 9, 2023
Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open-label FIRST studyMona Hamdy, Amal El-Beshlawy, Mônica P A Veríssimo, et al.
Blood Advances|November 30, 2021
Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority studyJanet L Kwiatkowski, Mona Hamdy, Amal El-Beshlawy, et al.
British Journal of Haematology|May 20, 2011
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell diseaseElliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, et al.
Pediatrics|July 16, 2014
Obstructive sleep apnea and sickle cell anemiaCarol L Rosen, Michael R Debaun, Robert C Strunk, et al.
British Journal of Haematology|March 6, 2019
Index of Pain Experience in Sickle Cell Anaemia (IPESCA): development from daily pain diaries and initial findings from use with children and adults with sickle cell anaemiaJamie M Kawadler, April Slee, Hanne Stotesbury, et al.
British Journal of Haematology|April 25, 2020
Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemicNoémi B A Roy, Paul Telfer, Perla Eleftheriou, et al.
Pediatric Blood & Cancer|November 18, 2014
Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trialNajibah A Galadanci, Shehu U Abdullahi, Musa A Tabari, et al.
Trials|August 26, 2015
Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trialJo Howard, Baba Inusa, Christina Liossi, et al.
Pageof 8